Possible problem with OptiPen Pro-1: Should diabetic patients continue to use this product? [2]

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1710-1711

  Goksen, Damla ^a,b   Darcan, Sukran ^a   Buyukinan, Muammer ^a   Kurt, Emine ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; ISOPHANE INSULIN;

DIABETIC PATIENT; DRUG DELIVERY SYSTEM; DRUG SUBSTITUTION; EVALUATION RESEARCH; HUMAN; INJECTION PISTOL; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; LETTER; PATIENT SATISFACTION; PUBLIC HEALTH; UNITED KINGDOM;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; EQUIPMENT FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN;

EID: 33746389791     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0605     Document Type: Letter

References (1)

1. Diabetes UK: Possible fault in OptiPen Pro-1 [article online], 2005. Available at http://www.diabetes.org.uk/news/jan05/MHRA.htm. Accessed 15 February 2006